Cardiac Insight
Cardiac Insight: Innovating ECG diagnostics with advanced wearable sensors and automated software.
Founded
2010Cardiac Insight: Innovating ECG diagnostics with advanced wearable sensors and automated software.
Founded with a mission to revolutionize cardiac care, Cardiac Insight develops advanced ECG diagnostic technology. Their core vision is to enhance early detection and management of cardiac conditions through innovative solutions. The company offers products such as wearable ECG sensors and automated ECG analysis software, specifically designed for healthcare providers, patients, and researchers. Cardiac Insight focuses on the medical device market, aiming to provide more accurate and efficient cardiac monitoring tools.
Notable figures associated with Cardiac Insight include leading cardiologists and healthcare technology experts. The company has received significant investment from venture capital firms specializing in medical technology. Key achievements include FDA approval for their flagship product, Cardea SOLO, and successful clinical trials demonstrating improved diagnostic accuracy. Cardiac Insight's impact is evident in its contribution to advancing cardiac health diagnostics, making early detection more accessible and reliable.
Companies similar to Cardiac Insight include InvisionHeart, AccurKardia, Medicalgorithmics and CardioWise.
Cardiac Insight was founded in 2010.
Cardiac Insight's headquarters is located in Bellevue, WA, US.
Cardiac Insight's most recent funding round was for $8M (USD) in February 2020.
As of Feb 11, 2020, Cardiac Insight has disclosed funding of $32.3M (USD). Undisclosed round amounts are excluded.
Cardiac Insight has 44 employees as of Feb 5, 2024.
CardioWise
cardiowiseinc.com
